- GSE offers platforms for businesses
- Soalihu highlighted pre-financing opportunities
- Amoah emphasized the importance of directing procurement
Moukthar Soalihu, the Managing Director of Intravenous Infusions PLC, has urged small and medium enterprises (SMEs) and indigenous companies to leverage the Ghana Stock Exchange (GSE) as a source of affordable capital for business growth.
Soalihu emphasized that the GSE offers platforms for businesses to raise capital at lower costs compared to bank loans.
While alternative markets are not free, he advised that the Ghana Alternative Market (GAX) is a significantly cheaper option than traditional bank financing, which often requires interest rates of 30% or more.
Beyond affordable capital, Soalihu highlighted pre-financing opportunities and enhanced business transparency as benefits of listing on the GSE.
The process of listing requires companies to establish functioning boards and implement accountability measures, which can improve overall business management.
Intravenous Infusions PLC itself demonstrated strong financial performance in 2023, despite macroeconomic challenges.
The company attributed its success to proactive board leadership and new strategies.
For the future, the company aims to increase revenue by 20% and expand its presence in the West African market through exports.
Abena Amoah, Managing Director of the GSE, emphasized the importance of directing procurement preferences towards companies listed on the GSE, such as Intravenous Infusions PLC.
She reiterated the GSE’s commitment to collaborating with investors and policymakers to create sustainable policies that support business growth and success.
